Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA-mandated safety program for isotretinoin, designed to prevent birth defects by requiring strict pregnancy testing, birth control, and patient education. Learn the 2025 rules, changes, and how to navigate the system.